JPRN-UMIN000017703招募中未知
Efficacy and safety of sofosbuvir and ribavirin in patients with chronic hepatitis C - Efficacy and safety of sofosbuvir and ribavirin
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology0 个研究点目标入组 500 人开始时间: 2015年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe multisystem disease, Severe immnodeficiency 2) P2regnant woman 3) Contraindication to ribavirin 4) Contraindication to sofosbuvir and ribavirin
研究者
相似试验
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ribavirin for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019469Toranomon Hospital100
已完成
不适用
Efficacy of sofosbuvir and ribavirin therapy in patients with genotype 2 hepatitis C virus: Significance of variants associated with resistance in NS3, NS5A and NS5B regiothe patients infected with genotype 2 HCV who received combination therapy with sofosbvir and rivabirin.JPRN-UMIN000018089Department of Gastroenterology & Hepatology, Saitama Medical University40
未知
不适用
Efficacy and safety on effects of ribavirin with sofosbuir and ledipasvir combination therapy for patients who failed to daclatasvir and asunaprevir combination therapyPatients with chronic hepatitis C, who failed to DCV/ASV therapyJPRN-UMIN000021790St. Marianna University School of Medicine20
招募中
Unknown
Efficacy and Safety of sofosbuvir/velpatasvir for HCV infected patients with decompensated LCJPRN-UMIN000050343Hokkaido University Hospital50
已完成
不适用
Efficacy and safety of sofosbuvir/belpatasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic liver disease infected with HCVJPRN-UMIN000035625Saitama Medical University35